Curis (CRIS) Operating Leases (2019 - 2026)
Curis' (CRIS) quarterly Operating Leases came in at $1.3 million in Q1 2026, down 50.0% YoY from $2.6 million in Q1 2025, and up 203.74% on a QoQ basis from $428000.0 in Q4 2025.
Curis (CRIS) Operating Leases (2019 - 2026) Analysis & Trends
Curis (CRIS) has 8 years of Operating Leases data on file, last reported at $1.3 million in Q1 2026.
- Quarterly Operating Leases fell 50.0% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 50.0% YoY) and the FY2025 annual result came in at $428000.0, down 85.51% from the prior year.
- Operating Leases climbed to $1.3 million in Q1 2026, from $428000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $4.5 million in Q2 2022 to a low of $428000.0 in Q4 2025.
- A 5-year average of $2.4 million and a median of $2.3 million in 2025 frame the typical range for Operating Leases.
- The widest YoY moves for Operating Leases: up 128.67% in 2025, down 85.51% in 2025.
- Tracing CRIS's Operating Leases over 5 years: stood at $3.9 million in 2022, then slumped by 62.22% to $1.5 million in 2023, then surged by 98.39% to $3.0 million in 2024, then plunged by 85.51% to $428000.0 in 2025, then surged by 203.74% to $1.3 million in 2026.
- The last three Operating Leases figures came in at $1.3 million (Q1 2026), $428000.0 (Q4 2025), and $740000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Curis | 3.32 Mn | -2.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 428,000.00 |
| Sep 30, 2025 | 740,000.00 |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 2.95 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 3.60 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.49 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 2.16 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Dec 31, 2022 | 3.94 Mn |
| Sep 30, 2022 | 3.10 Mn |
| Jun 30, 2022 | 4.50 Mn |
| Mar 31, 2022 | 2.94 Mn |
| Dec 31, 2021 | 5.04 Mn |
| Sep 30, 2021 | 4.54 Mn |
| Jun 30, 2021 | 5.30 Mn |